6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Appendix 4C and Quarterly Activities Report - March 2026
14m ago	Landis+Gyr Announces Sale of Rhebo to Everfield
14m ago	Lazard to Acquire Campbell Lutyens, Creating the Global Leader in Private Capital Advisory
24m ago	2026 ESMO GC \| Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations
36m ago	Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025

About

Immunome Inc (NASDAQ:IMNM) — investor relations, events, news, and company updates on 6ix.

Latest News

Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors

Immunome Announces Oral Presentation of Phase 3 RINGSIDE Data at 2026 ASCO Annual Meeting

Immunome Reports Full Year 2025 Financial Results and Provides Business Update

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Financials

Revenue

$6.94 M

Market Cap

$2.43 B

EPS

-2.43

Community Chat

Ask AI